violacein has been researched along with Acute Promyelocytic Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bos, CL; DurĂ¡n, N; Ferreira, CV; Justo, GZ; Peppelenbosch, MP; Versteeg, HH | 1 |
1 other study(ies) available for violacein and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Molecular mechanism of violacein-mediated human leukemia cell death.
Topics: Antigens, CD; Caspase 3; Caspases; Cell Death; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; HL-60 Cells; Humans; Indoles; K562 Cells; Leukemia, Promyelocytic, Acute; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; STAT1 Transcription Factor; STAT2 Transcription Factor; Trans-Activators; U937 Cells; Up-Regulation | 2004 |